{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T13:08:08Z","timestamp":1781269688275,"version":"3.54.1"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2016,7,7]],"date-time":"2016-07-07T00:00:00Z","timestamp":1467849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Science for Life Laboratory\u2013Astra Zeneca"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Heart failure (HF) with preserved (HFpEF) or reduced (HFrEF) ejection fraction is associated with poor prognosis and quality of life. While the incidence of HFrEF is declining and HF treatment is effective, HFpEF is increasing, with no established therapy. PREFERS Stockholm is an epidemiological study with the aim of improving clinical care and research in HF and to find new targets for drug treatment in HFpEF (https:\/\/internwebben.ki.se\/sites\/default\/files\/20150605_4d_research_appendix_final.pdf).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with new-onset HF (n = 2000) will be characterized at baseline and after 1-year follow-up by standardized protocols for clinical evaluation, echocardiography, and ECG. In one subset undergoing elective coronary bypass surgery (n = 100) and classified according to LV function, myocardial biopsies will be collected during surgery, and cardiac magnetic resonance (CMR) imaging will be performed at baseline and after 1 year. Blood and tissue samples will be stored in a biobank. We will characterize and compare new-onset HFpEF and HFrEF patients regarding clinical findings and cardiac imaging, genomics, proteomics, and transcriptomics from blood and cardiac biopsies, and by established biomarkers of fibrosis, inflammation, haemodynamics, haemostasis, and thrombosis. The data will be explored by state-of-the-art bioinformatics methods to investigate gene expression patterns, sequence variation, DNA methylation, and post-translational modifications, and using systems biology approaches including pathway and network analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this epidemiological HF study with biopsy studies in a subset of patients, we aim to identify new biomarkers of disease progression and to find pathophysiological mechanisms to support explorations of new treatment regimens for HFpEF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ejhf.599","type":"journal-article","created":{"date-parts":[[2016,7,7]],"date-time":"2016-07-07T03:26:56Z","timestamp":1467862016000},"page":"1287-1297","source":"Crossref","is-referenced-by-count":23,"title":["Rationale and Design of the PREFERS (Preserved and Reduced Ejection Fraction Epidemiological Regional Study) Stockholm Heart Failure Study: An Epidemiological Regional Study in Stockholm County of 2.1 Million Inhabitants"],"prefix":"10.1093","volume":"18","author":[{"given":"Cecilia","family":"Linde","sequence":"first","affiliation":[{"name":"Karolinska Institutet, Department of Medicine , Stockholm ,","place":["Sweden"]},{"name":"Karolinska University Hospital, Department of Cardiology , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Eriksson","sequence":"additional","affiliation":[{"name":"Karolinska University Hospital, Department of Clinical Physiology , Stockholm ,","place":["Sweden"]},{"name":"Karolinska Institutet, Department of Molecular Medicine and Surgery , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Hage","sequence":"additional","affiliation":[{"name":"Karolinska Institutet, Department of Medicine , Stockholm ,","place":["Sweden"]},{"name":"Karolinska University Hospital, Department of Cardiology , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e5kan","family":"Wall\u00e9n","sequence":"additional","affiliation":[{"name":"Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital , Stockholm ,","place":["Sweden"]},{"name":"Danderyd Hospital, Department of Cardiology , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"Persson","sequence":"additional","affiliation":[{"name":"Department of Cell and Molecular Biology, Science for Life Laboratory, Uppsala University , Uppsala ,","place":["Sweden"]},{"name":"Department of Medical Biochemistry and Biophysics, Science for Life Laboratory, Karolinska Institutet , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Corbascio","sequence":"additional","affiliation":[{"name":"Karolinska Institutet, Department of Molecular Medicine and Surgery , Stockholm ,","place":["Sweden"]},{"name":"Karolinska University Hospital, Department of Thoracic Surgery , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joakim","family":"Lundeberg","sequence":"additional","affiliation":[{"name":"Science for Life Laboratory, Royal Institute of Technology , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Maret","sequence":"additional","affiliation":[{"name":"Karolinska University Hospital, Department of Clinical Physiology , Stockholm ,","place":["Sweden"]},{"name":"Karolinska Institutet, Department of Molecular Medicine and Surgery , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Ugander","sequence":"additional","affiliation":[{"name":"Karolinska University Hospital, Department of Clinical Physiology , Stockholm ,","place":["Sweden"]},{"name":"Karolinska Institutet, Department of Molecular Medicine and Surgery , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Persson","sequence":"additional","affiliation":[{"name":"Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital , Stockholm ,","place":["Sweden"]},{"name":"Danderyd Hospital, Department of Cardiology , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Stockholm County\/Karolinska Institutet 4D heart failure investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,7,7]]},"reference":[{"key":"2026011721162884800_ejhf599-bib-0001","first-page":"e28","article-title":"Heart disease and stroke statistics\u20142014 update: a report from the American Heart Association","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"key":"2026011721162884800_ejhf599-bib-0002","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/HHF.0b013e318291329a","article-title":"Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association","volume":"6","author":"Heidenreich","year":"2013","journal-title":"Circ Heart Fail"},{"key":"2026011721162884800_ejhf599-bib-0003","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs105","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026011721162884800_ejhf599-bib-0004","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/CIRCULATIONAHA.111.080770","article-title":"Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes","volume":"126","author":"Steinberg","year":"2012","journal-title":"Circulation"},{"key":"2026011721162884800_ejhf599-bib-0005","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N Engl J Med"},{"key":"2026011721162884800_ejhf599-bib-0006","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/eurheartj\/ehs337","article-title":"Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies","volume":"34","author":"Pocock","year":"2013","journal-title":"Eur Heart J"},{"key":"2026011721162884800_ejhf599-bib-0007","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0002-8703(97)70126-1","article-title":"Congestive heart failure in patients with coronary artery disease: the gender paradox","volume":"134","author":"Mendes","year":"1997","journal-title":"Am Heart J"},{"key":"2026011721162884800_ejhf599-bib-0008","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/eurjhf\/hfn025","article-title":"Rationale and design of the Karolinska\u2013Rennes (KaRen) prospective study of dyssynchrony in heart failure with preserved ejection fraction","volume":"11","author":"Donal","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"2026011721162884800_ejhf599-bib-0009","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jchf.2013.10.006","article-title":"Developing therapies for heart failure with preserved ejection fraction: current state and future directions","volume":"2","author":"Butler","year":"2014","journal-title":"JACC Heart Fail"},{"key":"2026011721162884800_ejhf599-bib-0010","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/ejhf.416","article-title":"Heart failure with normal ejection fraction is uncommon in acute myocardial infarction settings but associated with poor outcomes: a study of 91 360 patients admitted with index myocardial infarction between 1998 and 2010","volume":"18","author":"Desta","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026011721162884800_ejhf599-bib-0011","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"key":"2026011721162884800_ejhf599-bib-0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095771","article-title":"Lack of salt-inducible kinase 2 (SIK2) prevents the development of cardiac hypertrophy in response to chronic high-salt intake","volume":"9","author":"Popov","year":"2014","journal-title":"PLoS One"},{"key":"2026011721162884800_ejhf599-bib-0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"2026011721162884800_ejhf599-bib-0014","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/ejechocard\/jep007","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography","volume":"10","author":"Nagueh","year":"2009","journal-title":"Eur J Echocardiogr"},{"key":"2026011721162884800_ejhf599-bib-0015","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jacc.2006.08.062","article-title":"Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence: results from the CHARM Echocardiographic Substudy-CHARMES","volume":"49","author":"Persson","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026011721162884800_ejhf599-bib-0016","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1093\/eurheartj\/ehm037","article-title":"How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology","volume":"28","author":"Paulus","year":"2007","journal-title":"Eur Heart J"},{"key":"2026011721162884800_ejhf599-bib-0017","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1093\/eurheartj\/ehr481","article-title":"Extracellular volume imaging by magnetic resonance imaging provides insights into overt and subclinical myocardial pathology","volume":"33","author":"Ugander","year":"2012","journal-title":"Eur Heart J"},{"key":"2026011721162884800_ejhf599-bib-0018","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1532-429X-15-92","article-title":"Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement","volume":"15","author":"Moon","year":"2013","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026011721162884800_ejhf599-bib-0019","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1542-474X.2001.tb00129.x","article-title":"The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. 1949","volume":"6","author":"Sokolow","year":"2001","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"2026011721162884800_ejhf599-bib-0020","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/eurheartj\/ehs305","article-title":"Prevalence, correlates, and prognostic significance of QRS prolongation in heart failure with reduced and preserved ejection fraction","volume":"34","author":"Lund","year":"2013","journal-title":"Eur Heart J"},{"key":"2026011721162884800_ejhf599-bib-0021","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","article-title":"EuroQol: the current state of play","volume":"37","author":"Brooks","year":"1996","journal-title":"Health Policy"},{"key":"2026011721162884800_ejhf599-bib-0022","article-title":"Patients self-assessment of their congestive heart failure II. Content reliability and validity of a new measure: the Minnesota Living with Heart Failure Questionnaire","volume":"3","author":"Rector","year":"1987","journal-title":"Heart Fail"},{"key":"2026011721162884800_ejhf599-bib-0023","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1160\/TH11-11-0760","article-title":"Impaired fibrinolytic capacity and increased fibrin formation associate with myocardial infarction","volume":"107","author":"Leander","year":"2012","journal-title":"Thromb Haemost"},{"key":"2026011721162884800_ejhf599-bib-0024","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1160\/TH11-11-0779","article-title":"Platelet-derived microparticles during and after acute coronary syndrome","volume":"107","author":"Skeppholm","year":"2012","journal-title":"Thromb Haemost"},{"key":"2026011721162884800_ejhf599-bib-0025","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.thromres.2011.09.027","article-title":"Release of endothelial microparticles in vivo during atorvastatin treatment; a randomized double-blind placebo-controlled study","volume":"129","author":"Mobarrez","year":"2012","journal-title":"Thromb Res"},{"key":"2026011721162884800_ejhf599-bib-0026","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/sji.12076","article-title":"Effect of lipopolysaccharide administration on the number, phenotype and content of nuclear molecules in blood microparticles of normal human subjects","volume":"78","author":"Soop","year":"2013","journal-title":"Scand J Immunol"},{"key":"2026011721162884800_ejhf599-bib-0027","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1097\/HJH.0b013e3282170ada","article-title":"Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA)","volume":"25","author":"Muller-Brunotte","year":"2007","journal-title":"J Hypertens"},{"issue":"Suppl","key":"2026011721162884800_ejhf599-bib-0028","first-page":"263","article-title":"Disturbances of collagen type 1 metabolism predict long-term mortality in systolic heart failure [abstract]","volume":"17","author":"L\u00f6fsj\u00f6g\u00e5rd","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2026011721162884800_ejhf599-bib-0029","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2459\/01.JCM.0000435617.86180.0b","article-title":"Biomarkers of collagen type I metabolism are related to B-type natriuretic peptide, left ventricular size, and diastolic function in heart failure","volume":"15","author":"L\u00f6fsj\u00f6g\u00e5rd","year":"2014","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"2026011721162884800_ejhf599-bib-0030","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/eurheartj\/ehn098","article-title":"Impact of collagen type I turnover on the long-term response to cardiac resynchronization therapy","volume":"29","author":"Garcia-Bolao","year":"2008","journal-title":"Eur Heart J"},{"key":"2026011721162884800_ejhf599-bib-0031","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1210\/me.2006-0172","article-title":"Molecular model of human CYP21 based on mammalian CYP2C5: structural features correlate with clinical severity of mutations causing congenital adrenal hyperplasia","volume":"20","author":"Robins","year":"2006","journal-title":"Mol Endocrinol"},{"key":"2026011721162884800_ejhf599-bib-0032","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.114.010637","article-title":"Phenomapping for novel classification of heart failure with preserved ejection fraction","volume":"131","author":"Shah","year":"2015","journal-title":"Circulation"},{"key":"2026011721162884800_ejhf599-bib-0033","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s12471-016-0810-1","article-title":"Understanding heart failure with preserved ejection fraction: where are we today?","volume":"24","author":"van Heerebeek","year":"2016","journal-title":"Neth Heart J"},{"key":"2026011721162884800_ejhf599-bib-0034","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.jacc.2012.04.064","article-title":"What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-preserved, and I-PRESERVE?","volume":"60","author":"Campbell","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026011721162884800_ejhf599-bib-0035","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.acvd.2013.11.002","article-title":"Baseline characteristics of patients with heart failure and preserved ejection fraction included in the Karolinska Rennes (KaRen) study","volume":"107","author":"Donal","year":"2014","journal-title":"Arch Cardiovasc Dis"},{"key":"2026011721162884800_ejhf599-bib-0036","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/ejhf.137","article-title":"Association between cardiovascular vs. non-cardiovascular co-morbidities and outcomes in heart failure with preserved ejection fraction","volume":"16","author":"Lund","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026011721162884800_ejhf599-bib-0037","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/ejhf.291","article-title":"New echocardiographic predictors of clinical outcome in patients presenting with heart failure and a preserved left ventricular ejection fraction: a subanalysis of the Ka (Karolinska) Ren (Rennes) Study","volume":"17","author":"Donal","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2026011721162884800_ejhf599-bib-0038","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ejheart.2008.01.017","article-title":"BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction","volume":"10","author":"Grewal","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"2026011721162884800_ejhf599-bib-0039","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/CIRCHEARTFAILURE.111.962654","article-title":"Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial","volume":"4","author":"Anand","year":"2011","journal-title":"Circ Heart Fail"},{"key":"2026011721162884800_ejhf599-bib-0040","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"key":"2026011721162884800_ejhf599-bib-0041","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jacc.2010.11.013","article-title":"Assessment of myocardial fibrosis with cardiovascular magnetic resonance","volume":"57","author":"Mewton","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026011721162884800_ejhf599-bib-0042","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s11897-013-0160-x","article-title":"Circulating biomarkers in patients with heart failure and preserved ejection fraction","volume":"10","author":"O\u2019Meara","year":"2013","journal-title":"Curr Heart Fail Rep"},{"key":"2026011721162884800_ejhf599-bib-0043","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J. Am Coll Cardiol"},{"key":"2026011721162884800_ejhf599-bib-0044","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1161\/CIRCHEARTFAILURE.113.000539","article-title":"Myocardial titin hypophosphorylation importantly contributes to heart failure with preserved ejection fraction in a rat metabolic risk model","volume":"6","author":"Hamdani","year":"2013","journal-title":"Circ Heart Fail"},{"key":"2026011721162884800_ejhf599-bib-0045","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1161\/CIRCULATIONAHA.114.013215","article-title":"Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin","volume":"131","author":"Zile","year":"2015","journal-title":"Circulation"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fejhf.599","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/18\/10\/1287\/66380407\/eurjhf_18_10_1287.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/18\/10\/1287\/66380407\/eurjhf_18_10_1287.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T02:17:18Z","timestamp":1768702638000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/18\/10\/1287\/8423230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,7]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,7,7]]},"published-print":{"date-parts":[[2016,10,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.599","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,10]]},"published":{"date-parts":[[2016,7,7]]}}}